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The RAW264 murine macrophage cell line was used as a model to examine the role of the tat and nef gene
products in the transcription regulation of the human immunodeficiency virus type 1 (HIV-1) long terminal
repeat (LTR) in macrophages. Contrary to claims that the activity of the HIV-1 LTR responds poorly in rodent
cells to trans activation by the viral tat gene product, cotransfection of RAW264 cells with a tat expression
plasmid in transient transfection assays caused a >20-fold increase in reporter gene expression that was
inhibited by mutations in the TAR region. RAW264 cells stably transfected with the tat plasmid displayed
similarly elevated HIV-1 LTR-driven reporter gene activity. By contrast to previous reports indicating a
negative role for nef in HIV transcription, cotransfection of RAW264 cells with a nef expression plasmid trans
activated the HIV-1 LTR driving either a chloramphenicol acetyltransferase or a luciferase reporter gene. The
action of nef was specific to the LTR, as expression of nef had no effect on the activity of the simian virus 40,
c-fins, urokinase plasminogen activator, or type 5 acid phosphatase promoter. trans-activating activity was also
manifested by a frameshift mutant expressing only the first 35 amino acids of the protein. The effects ofnefwere
multiplicative with those of tat gene product and occurred even in the presence of bacterial lipopolysaccharide,
which itself activated LTR-directed transcription. Examination of the effects of selected mutations in the LTR
revealed that neither the KB sites in the direct repeat enhancer nor the TAR region was required as a cis-acting
element in nef action. The action of nef was not species restricted; it was able to trans activate in the human
monocyte-like cell line Mono Mac 6. The presence of a nef expression cassette in a neomycin phosphotrans-
ferase gene expression plasmid greatly reduced the number of G418-resistant colonies generated in stable
transfection of RAW264 cells, and many of the colonies that were formed exhibited very slow growth. The
frameshift mutant was also active in reducing colony generation. Given the absence of any effect of the
frameshift mutation on nef function, its actions on macrophage growth and HIV transcription are discussed in
terms of the role of the N-terminal 30 amino acids and of stable secondary structures in the mRNA.
The production of human immunodeficiency virus type 1
(HIV-1) viral RNA is controlled by cis-acting elements in the
long terminal repeat (LTR), which includes a TATA box, three
Spl sites, and an enhancer region composed of two directly
repeated binding sites for the NF-KB/c-rel family of cellular
transcription factors (1, 12, 20). Transcription of the integrated
HIV-1 provirus is also regulated by viral proteins which act
directly or indirectly on the viral promoter, the LTR. The best
characterized of these viral regulatory proteins is the early
gene product, tat (32). The cis-acting element responsive to tat
is the TAR region located immediately downstream of the
LTR transcription start site. Unlike typical enhancers, this
element functions in a position- and orientation-dependent
manner. The secondary structure of TAR RNA may function
as a tether bringing tat close to the transcriptional apparatus,
facilitating interaction between the trans activator and the
promoter (2). Alternatively, there is evidence suggesting a role
for tat in transcription elongation and nuclear export, process-
ing, translation, or stability of HIV transcripts (27, 32).
Most of the studies of HIV LTR function in macrophages
have taken place in the absence of the tat gene product, and
the cell lines commonly used in human studies, such as the
U937 promonocyte line, are relatively immature (7). Because
of the availability of a great diversity of cell lines and primary
macrophage sources in the mouse, and the potential power of
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transgenic animals for the study of the regulation of the HIV
LTR, we decided to undertake an examination of the regula-
tion of the HIV LTR in a well-characterized mouse macro-
phage cell line, RAW264. Transgenic animals with an inte-
grated reporter gene linking the HIV LTR to the bacterial
chloramphenicol acetyltransferase (CAT) gene expressed the
reporter in T cells and macrophages (22). More recently,
Corboy et al. (5) showed that the LTR of HIV-1 strains
isolated from patient brain directed neuron-specific expression
of lacZ in transgenic mice. These data suggest that HIV-1
tissue specificity is preserved across species. However, there
have been several suggestions that the tat gene product does
not trans activate in rodent cells (8, 32).
Of the viral regulatory gene products, nef is by far the most
abundant early viral transcript (10, 13, 16, 26). The protein
product of nef is a 27-kDa protein of approximately 200 amino
acids transcribed from an open reading frame which overlaps
the 3' end of the env gene and extends into the 3' LTR (32). It
is a nonnuclear protein which undergoes posttranslational
modification by myristoylation and is associated with cell
membranes. Studies of the function of nef in HIV-1 infection
in vitro have generated conflicting conclusions. There is some
evidence that nef is a negative regulator of viral transcription
(31), but others claimed that functional mutants in nef had no
effect on viral replication (14). Still other investigations have
suggested a positive function of nef in virus replication (18), a
conclusion supported by studies of nef functional mutants in a
simian model of AIDS (17).
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The long period of apparent viral latency in HIV-1 infection
that occurs before development of disease may be due in part
to low-level productive infection of mononuclear phagocytes
which are resistant to the cytopathic effect of the virus and act
as a virus reservoir (22). The aim of the work reported in this
paper is to establish RAW264 as a useful model in which to
study the regulation of the HIV LTR in macrophages. The
study involves an examination of the interactions between the
LTR, the tat and nef viral regulatory genes, cis-acting elements
of the LTR, and bacterial lipopolysaccharide (LPS), a physio-
logical regulator of macrophage function and HIV LTR-
directed transcription. The results contradict claims that Tat is
inactive in the mouse and suggest that nef could have a
macrophage-specific role in the HIV-1 life cycle.
MATERIALS AND METHODS
Cells and transfection. The RAW264 murine macrophage
line, obtained from the American Type Culture Collection,
and the human monocyte line Mono Mac 6 (34), obtained
from H. Ziegler-Heitbrock (Institute for Immunology, Mu-
nich, Germany), were maintained in RPMI 1640 medium
supplemented with 5 or 10% (vol/vol) fetal calf serum, 2 mM
L-glutamine, and penicillin-streptomycin in bacteriological
plastic petri dishes. The fibroblast-like simian line COS-1 was
obtained from the American Type Culture Collection and
maintained on tissue culture plastic in Dulbecco modified
Eagle medium with 10% (vol/vol) fetal calf serum. Cells were
transfected by electroporation, using a Bio-Rad Gene Pulser
and Capacitance Extender (set at 750 V cm ' and 960-pLF
capacitance) at room temperature in 200 [L of medium plus
10% (vol/vol) fetal calf serum (3). CAT assays were performed
as described by Gorman et al. (11) and quantitated by using an
AMBIS Radioanalyser. Luciferase assays were carried out by
using the GeneLight system supplied by Promega and a
Bertholdt luminometer. In each case, activities were normal-
ized to protein concentration determined by using a modified
Bradford assay (Bio-Rad). Stable transfectants were generated
by using the same electroporation procedure with linearized
plasmids carrying the neomycin phosphotransferase (neo)
gene. Following overnight growth in nonselective medium, 5 x
105 cells per well were distributed in a 24-well plate in 1 ml of
medium with G418 (Geneticin; GIBCO-BRL) at 200 pLg/ml.
The selective medium was replaced every 2 or 3 days; after 10
to 14 days, clones were counted, selected, and expanded
through culture in gradually increasing volumes of selective
medium. All replicates involved fully independent transfec-
tions and assays of cells.
Plasmids. The Tat expression plasmid pJKC63.4.1 is a
Moloney retroviral vector carrying a synthetic tat gene under
the control of the viral LTR and a neo gene under the control
of the simian virus 40 (SV40) early promoter (9) (a gift from
Jonathan Karn, MRC Laboratory of Molecular Biology, Cam-
bridge, England). pHIV-CAT (or pU3R-II1), which carries the
CAT gene under the control of the HIV-1 LTR (29), and
pHIV-CATAKB, identical to pHIV-CAT except for GGGG-
to-GCTC mutations in both copies of the direct repeat (24),
were gifts of Gary Nabel (Howard Hughes Medical Institute,
University of Michigan Medical Center, Ann Arbor, Mich.).
pSV2CAT (11) contains the SV40 early promoter linked to
CAT. The alternative HIV-1 LTR-CAT plasmid pD5.3.3 was a
gift from Jonathan Karn, as were its SAS, SSA, and SAA
variants containing antisense mutations of the DNA leading to
changes in the secondary structure of TAR RNA in the bulge
region, the loop region, and both bulge and loop regions,
respectively (9). HIV-luciferase reporter plasmids were con-
structed by ligating an XhoI-to-HindIII fragment excised from
pHIV-CAT or pHIV-CATAKB into the luciferase expression
plasmid pGL2-Basic (Promega) to generate pGL-LTR and
pGL-LTRAKB, respectively. A 4-bp deletion in the TAR
region of pGL-LTR was created by cutting the plasmid at the
unique Sacl site in the TAR loop region (9), removing the
single-stranded ends with T4 DNA polymerase, and religating
the plasmid to generate pGL-LTRATAR. The c-fms promoter
plasmid pGL3.5fms has been described by Xie et al. (33). A
urokinase plasminogen activator promoter construct was pro-
duced by ligating the 7-kb XbaI fragment from puPACAT2 (3)
into the multiple cloning site of pGL2-Basic to produce
pGL-uPA. pGL-MAP1 contains the promoter of murine type
5 acid phosphatase gene described in reference 4. In pGL2-
Control (Promega), the luciferase gene is under the control of
the SV40 early promoter and enhancer. Nef expression plas-
mids were pNEF, containing the nef coding region extending
only four nucleotides 3' of the nef stop codon under the control
of the cytomegalovirus (CMV) immediate-early promoter,
pNEF-fs, a version of this plasmid with a frameshift at the
XhoI site, and pNEF-LTR, the same vector with additional 3'
untranslated U3 and R sequence up to the HinidIII site (14)
(gifts of Stephen Hammes, Howard Hughes Medical Institute,
Duke University Medical Center, Durham, N.C.). The neo
expression plasmid pMClNeoPolyA was obtained from Strat-
agene. The nef expression plasmids pNEF-Neo and pNEF-fs-
Neo were constructed by blunt-ended ligation of the XhoI-
HindIII neo fragment of pMClNeoPolyA into the EcoRI site
of pNEF and pNEF-fs. The control CMV promoter expression
plasmid was pcDNAI (Invitrogen).
Reagents. Bacterial LPS from Salmonella minnesota R595,
obtained from List Biological Laboratories (Campbell, Calif.),
was dissolved by sonication in 0.1% triethylamine.
RESULTS
Tat and HIV-1 LTR-directed transcription in RAW264 cells.
The HIV-l LTR reporter construct pHIV-CAT transiently
transfected into RAW264 cells produced substantial CAT
activity (Fig. IA), but the activity was elevated still further, up
to 20-fold, in stable transfectants of RAW264 cells expressing
the HIV-1 tat gene product. A representative tat-transfected
clone is compared with the parent line in Fig. IA. trans
activation in the tat-producing clones was specific for the
HIV-1 LTR in that no effect was seen on the SV40 early
promoter in the positive control vector pSV2CAT (Fig. lA).
All tat-transfected clones that were positive for trans activation
appeared to be slower growing than RAW264, as assessed by a
30 to 50% decrease in [3H]thymidine incorporation (data not
shown), but there were no obvious effects on cell morphology.
Previous reports have suggested that trans activation by tat is
restricted to human and primate cells. trans activation of the
LTR by tat requires sequences in the TAR region and is
believed to involve an interaction between the activator and a
stable stem-loop structure formed in nascent TAR RNA (9).
Hence, we decided to confirm that the response to tat in the
RAW264 cells was mediated via the tat activation region of
TAR. In Fig. lB, mutations predicted to alter the secondary
structure of TAR RNA resulted in changes to basal expression
from the LTR in RAW264 cells. Mutation of the bulge or loop
alone (SAS, SSA [9]) halved basal expression. The double
mutation, both bulge and loop (SAA), reduced basal expres-
sion by eightfold. The effect on tat-stimulated expression was
more marked; 9- and 5-fold reductions were induced by the
SAS and SSA mutants, respectively, and the double mutation
causing a 30-fold reduction (Fig. IB). The ability of tat to trans
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FIG. 1. (A) The activity of the HIV-1 LTR in control and Tat-
producing RAW264 murine macrophage cell lines. RAW264 cells
were transfected with the expression vector pJKC63.4.1, which has a
neo gene as well as a tat expression cassette (9). Control RAW264 cells
and a representative tat-expressing cell line, RAWtatG8, were trans-
fected with 10 p.g of pHIV-CAT or pSV2-CAT by electroporation as
described in Materials and Methods. After 48 h, the cells were
harvested and assayed for CAT enzymatic activity. Values are averages
of two independent transfections. Results for RAWtatG8 are repre-
sentative of results for four other tat-expressing clones analyzed (see
also RAWtatG5 in panel B). (B) Effects of mutants in the TAR region
of the HIV-1 LTR on basal and Tat trans-activation activity in
RAW264 cells. Control RAW264 or tat-expressing RAWtatG5 cells
were transfected by electroporation with wild-type HIV-1 LTR re-
porter plasmid pD5.3.3 and derivatives of pD5.3.3 with antisense
mutations in the TAR sequence predicted to cause alterations in the
structure of the RNA stem-loop in nascent mRNA. Plasmid SAS is
altered in the bulge region in the TAR upper stem, SSA is altered in
the loop region, and SAA is mutated in the both the bulge and loop
regions (9). After 24 h, the cells were harvested and CAT enzyme
activity was assayed. The results are averages of duplicate independent
transfections and are typical of results of three experiments.
activate in the murine macrophages was also observed when
the expression plasmid was cotransfected with either the
HIV-CAT reporter construct (Table 1) or an HIV-luciferase
reporter plasmid (Table 2) in transient transfections. In the
latter case, a mutant LTR in which a 4-bp deletion of the TAR
region had been made (pGL2-LTRATAR) was almost com-
pletely unresponsive to tat. Taken together, the data indicate
that the effect of tat in the stably transfected cell lines and in
transient transfections is specific to LTR-driven reporter con-
TABLE 1. Comparison of the effects of cotransfection with Nef and
Tat expression plasmids on the activity of the HIV-1 LTR in
RAW264 murine macrophages and COS-1 simian fibroblasts"
CAT activity (% transacetylation/
Cotransfected ,ug of protein/h)"
plasmid(s)
RAW264 COS-1
None 0.18 0.52
Control vector 0.14 ND
Tat 5.80 99.1
Nef 0.70 0.27
Tat + Nef 15.8 75.7
Tat + control vector ND 83.4
" Cells were transfected by electroporation with 2.5 jig of pHIV-CAT reporter
together with 2.5 jLg of pNEF (Nef expression plasmid), pJKC63.4.1 (Tat
expression plasmid), and/or a control plasmid (pcDNAI) as indicated, and CAT
activity was assayed 48 h later.
b Mean of duplicate transfections varying by less than 10% from the mean. The
transfections of RAW264 and COS-l cells were performed in parallel, using the
same reagents. The experiment is representative of three. ND, not determined.
structs with an intact TAR region and that there is no
significant difference between the RAW264 murine macro-
phage cell line and human and simian lines reported in the
literature in terms of responsiveness to tat.
Effects of Nef on transcription directed by the HIV LTR. As
noted in the introduction, nef has variously been attributed
negative or negligible effects on transcription directed by the
HIV LTR. When pHIV-CAT was transfected into RAW264
cells together with a nef expression plasmid, either pNEF or
pNEF-LTR, which contains more of the 3' LTR, there was a
three- to fivefold increase in CAT activity (Fig. 2A; Table 1).
The increase in CAT expression induced by the nef plasmids
was not dependent on the production of a full-length protein,
since pNEF-fs, which encodes a 46-amino-acid protein of
which the initial 35 correspond to the N terminus of nef, was
TABLE 2. Effects of mutations in the direct repeat (AKB) and
TAR (ATAR) regions of the HIV-LTR on basal activity and
responsiveness to bacterial LPS, Nef, and Tat"
Luciferase activity
Reporter Cotransfected (RLU/jig of protein)"plasmid(s)
Control +LPS
pGL-LTR Control 9,400 20,700
Tat 81,400 99,300
Nef 23,400 33,600
Tat + Nef 194,300 257,500
pGL-LTRAKB Control 1,600 3,400
Tat 11,600 24,500
Nef 3,100 8,800
Tat + Nef 30,000 64,300
pGL-LTRATAR Control 11,900 23,000
Tat 19,400 32,400
Nef 35,800 55,400
Tat + Nef 54,600 112,000
"RAW264 cells were cotransfected with 10 jig of HIV LTR-luciferase
reporter plasmid (pGL-LTR; wild type or mutant as indicated) plus PJKC63.4.1
(the Tat expression plasmid; 2 jig) or pNEF (Nef expression plasmid; 10 jig).
Control vector plasmid (pcDNAI) was added as required to equalize quantities
of transfected DNA to a total of 22 jig per transfection. After 24 h, cells were
harvested and assayed for luciferase activity.
"Average of independent duplicate transfections varying by less than 10%
around the mean. The experiment is representative of three. RLU, relative light
units.
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FIG. 2. (A) trans activation of the HIV-1 LTR in RAW264 cells by the nef gene. RAW264 cells or tat-expressing RAWtatG8 cells were
cotransfected with 10 jig of pHIV-CAT and either pNEF, pNEF-fs, pNEF-LTR, or a control CMV promoter vector (pcDNA1) at a 2:1 molar ratio
by electroporation as described in Materials and Methods. After 48 h, CAT activity was assayed and is expressed as percent transacetylation per
microgram of protein extract assayed. Values shown are means of either triplicate transfections or two sets of duplicates. The experiment is
representative of three except that the small stimulus observed in response to pcDNA1 was not observed elsewhere. (B) Effect of LPS on the dose
dependence of trans activation of the HIV-1 LTR in RAW264 cells by nef. RAW264 cells were cotransfected with 10 ,ug of pGL-LTR and 2, 5,
and 10 ,ug of pNEF. Total DNA transfected was made up to 20 p.g with the CMV promoter expression vector pcDNA1. Each transfection mixture
was divided into two, and half of the cells were treated with 500 ng of LPS per ml. After 24 h, the cells were harvested and assayed for luciferase
activity. Results are averages of two independent series of duplicate transfections. (C) trans-activating effects of nef in Mono Mac 6 cells. Mono
Mac 6 human macrophages were cotransfected with 10 p.g of pGL-LTR and 10 pug of either pNEF, pNEF-fs, pNEF-LTR, or a control CMV
promoter vector (pcDNA1) by electroporation as described in Materials and Methods. After 24 h, cells were harvested and assayed for luciferase
activity. Two sets of results from independent experiments are shown, both normalized for reporter-only luciferase activity. Values are averages
of duplicate transfections varying by less than 10% from the mean. (D) Additive responses to nef and tat in Mono Mac 6 cells. Mono Mac 6 human
macrophages were cotransfected with 10 ,ug of pGL-LTR and one or both of Tat expression plasmids pJKC63.4.1 (2 ,ug) and pNEF (10 p.g). CMV
vector DNA (pcDNA1) was added as required to equalize quantities of transfected DNA to 22 iLg in total. After 24 h, cells were harvested and
assayed for luciferase activity. Results from two independent experiments are shown. Values are averages of independent duplicate transfections
varying by less than 10% from the mean. RLU, relative light units.
equally effective as a trans activator. The response of RAW264
macrophages to the nef expression plasmids could not be
attributed to transfection with the CMV promoter in the
expression plasmid. Transfection with a control plasmid alone
sometimes led to an increase of at most 1.5-fold in CAT
expression controlled by the LTR (as seen in Fig. 2A but not
evident in the more typical experiment in Table 1). trans
activation by nefwas equally evident in tat-stable transfectants
of RAW264 (Fig. 2A) and when it was cotransfected tran-
siently with the tat expression plasmid (Table 1), indicating that
the actions of the two viral gene products are multiplicative.
Finally, the effects of nefwere also evident when the expression
plasmid was cotransfected with an alternative reporter, pGL-
LTR, in which the HIV LTR was placed upstream of the
luciferase gene. A dose-response curve demonstrating increas-
ing luciferase activity in response to increasing amounts of nef
expression plasmid is shown in Fig. 2B.
Because the actions of both tat and nef in RAW264 con-
trasted with previous reports, with respect to either tissue
specificity or the nature of the response, comparative transient
cotransfection studies were performed in RAW264 murine
macrophages and COS-1 simian fibroblasts, in which transcrip-
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TABLE 3. Specificity of tirans activation of the HIV-LTR by Nef in
RAW264 murine macrophages"
Luciferase aictivity
Promoter (RLU/4Lg of protein)" Fold change
Control +Nef
HIV LTR 1,900 10,200 5.4
SV40 promoter/enhancer 13,8t)0 19,500 1.4
Urokinase 40)0 35f) 0.9
Type 5 acid phosphatase 650 9()( 1.4
c-fins 65 60 0.9
" RAW264 cells were transfected by electroporation with 11) 1tg of reporter
construct in which the luciferase reporter gene was under the control of the
promoters indicated together with 1t) ,ug of either control vcctor (pcDNAI) or
the Nef expression plasmid pNEF. Details of the reporter plasmids are provided
in Materials and Methods. After 24 h, the cells were harvested and luciferase
activity was determined as described in Materials and Methods.
" Average of two independent experiments. RLU, relativc light units.
tional repression by nef had been observed (14). By contrast to
the fourfold trans activation seen in RAW264 cells transfected
in parallel, nef caused a slight repression in COS-1 cells that
was only marginally greater than that caused by the parent
vector (Table 1). We have seen no fundamental species
difference in the activity of the HIV LTR in macrophages, but
the effect of nefwas so unexpected that it became important to
confirm the positive effect of nef on transcription in a human
macrophage line. Using the luciferase reporter plasmid for
greater sensitivity, we examined the effects of nef in the human
monocyte cell line Mono Mac 6 (Fig. 2C). pNEF and pNEF-fs
both increased LTR-driven reporter gene expression three- to
fivefold in Mono Mac 6 cells. pNEF-LTR was somewhat less
active, perhaps as a result of promoter competition between
the extended LTR in the expression plasmid and the reporter
plasmid (14). As in RAW264 murine macrophages, the effects
of cotransfection with nef and tat expression plasmids in Mono
Mac 6 cells were multiplicative (Fig. 2D). These data indicate
that the actions of tat and nef are not species specific. Because
RAW264 cells are more readily transfected than Mono Mac 6
cells, further delineation of the mechanism of action of nef in
macrophages was carried out in the mouse system.
cis-acting elements involved in trans activation of the HIV
LTR by nef and bacterial LPS. Bacterial LPS has been
implicated as a physiological regulator of HIV-1 transcription
in monocytes/macrophages (25). Figure 2B shows that in
RAW264 cells transfected with pGL-LTR, treatment with LPS
caused a trans activation that was similar in magnitude to the
effect of nef. The effect of LPS was additive with the action of
nef. This finding indicates that LPS and nef act via different
pathways and eliminates any possibility that the action of the
nef expression plasmid is due to contamination with LPS or any
compound with a similar mode of action. Table 3 provides
additional evidence for the specificity of the effect of nef for the
HIV LTR. Cotransfection with nef had no effect on the activity
of the SV40 promoter/enhancer (which is LPS inducible [un-
published data]), the urokinase plasminogen activator pro-
moter (which can be induced by phorbol esters and growth
factors [3]), or the macrophage-specific c-fms (33) and type 5
acid phosphatase (4) promoters.
Two major cis-acting elements have been implicated in the
regulated transcription of the HIV LTR: the direct repeat
enhancer containing binding sites for the NF-KB transcription
factor family and the TAR sequence mentioned above. LPS
has been reported to induce NF-KB in macrophages and to
mediate some of its effects on HIV transcription via this
TABLE 4. Effect of Nef on the generation of stable transfectants of
RAW264 cells"
Rclative frequency of stable transfectants
Plasmid
Expt I Expt 2 Expt 3 Expt 4
pNEF (HindIII) 0.82 1.13
pNEF (KpnI) 0.99
pNEF (Sspl) 0.22 0.22
pNEF (BstEII) 0.04 0.09
pNEF-fs (SspI) 0.54
pNEF-fs (HindIIl) 2.08 1.40
pNEF-fs (KpnI) 1.31 1.02
pNEF-fs (BstEII) 0.10 0.12 0.17
" Cells were transfected with 2.5 jig ot either a wild-typc (pNEF) or frameshift
mutant (pNEF-fs) Nef expression plasmid also containing the Neo-resistance
cassette from pMCINeoPolyA (see Materials and Methods). After 24 h, G418
was added at 200 jLg/ml. G418-resistant colonies (>50) cells) were counted after
14 days in culture. Prior to traInsfection, the expression plasmids were linearized
with different restriction enzymes as indicated in brackets. Sspl cuts outside both
the Nef and Neo expression cassettes. The Hioidlll site lies between the CMV
promoter and the ncf start codon. B.sEII cuts between the 3' untranslated region
of toef and the polyadenylation signal encoded by the vector and, Kpol cuts 226
bp into the tief coding sequence. Results are expressed relative to the frequency
of Neo-resistant colonies arising from transfection with the linearized control
plasmid, pMCINeoPolyA, which varied from 72 to 201 colonies per 1()" cells. In
each of four independent experiments shown, the results are averages of
duplicate independent transfections.
pathway (20, 25). A reporter construct containing mutations in
the direct repeat that would abolish NF-KB binding (pGL-
LTRAKB) was sixfold less active than the parent plasmid in
RAW264 cells but was trans activated to the same extent by tat,
nef, and LPS (Table 2). Again, the effects of the three agents
were multiplicative. The basal activity of the HIV LTR was
unaffected by a 4-bp deletion of the TAR sequence around the
loop in the predicted stem-loop structure formed in TAR RNA
(pGL-LTRATAR), but as noted above, tat stimulation was
almost eliminated. This mutation also had no effect on the
actions of LPS and nef, which together caused a 10-fold trans
activation of the mutated reporter construct. Note that the
failure of the TAR deletion to alter basal activity differs from
the inhibitory effect of the TAR antisense mutations shown in
Fig. IB, suggesting that the latter mutations act on basal
expression independently of their potential effects on RNA
secondary structure. These findings suggest that the cis-acting
elements involved in the actions of nef function independently
of those required for a response to LPS and tat.
Stable transfection of RAW264 cells with nef expression
plasmids. Because the nef gene product is a nonnuclear
protein, we considered it likely that its ability to increase the
transcriptional activity of the LTR in RAW264 cells occurred
indirectly as a result of an alteration in cell function. The
cotransfection studies described above eliminated the possibil-
ity that nef altered expression of other genes that are macro-
phage specific or inducible in RAW264 cells. To analyze the
actions of nef on other aspects of macrophage function, we
attempted to produce stable transfectants of RAW264 cells
expressing nef. RAW264 were transfected with the selectable
plasmid pMClNeoPolyA or with pNEF-Neo or pNEF-fs-Neo.
In side-by-side comparisons, substantially fewer G418-resistant
colonies were generated when plasmids with functional expres-
sion of either Nef and Nef-fs were used as opposed to
pMClNeoPolyA (Table 4). Many of the colonies that were
formed were generally smaller; they reached a moderate size
and then stopped growing. Figure 3 shows an example of such
a colony, which maintained a constant size after 7 weeks in
culture in selective medium. The cells within the colony appear
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FIG. 3. The effect of nef on the generation of G418-resistant colonies in RAW264 cells transfected with a neo cassette. (A) G418-resistant cells
that form one quadrant of a colony of RAW264 transfected with pNEF-Neo. The colony originated from a focus comprising about 20 cells arising
from a foundation clone by 7 days after transfection. It had expanded to this size after a further 41 days in G418 medium which was replaced at
3- to 4-day intervals. (B) Untransfected RAW264 cells growing in nonselective medium.
smaller, clumped, and more rounded and with less tendency to
spread on the culture dish. These data suggested that expres-
sion of Nef and Nef-fs was cytotoxic and/or caused cytostasis.
To confirm that the cytotoxic or cytostatic effects of the nef
expression plasmids were attributable to gene products of the
plasmids rather than the plasmid DNA per se or some
alteration to the neo gene, the plasmids were linearized with
restriction enzymes at different sites. The control plasmids that
were ineffective at generating colonies had been linearized at
the SspI site, which leaves the neo and nef cassettes intact. A
single HindlIl site is located between the CMV promoter and
the sequences coding for Nef and Nef-fs. Hence, digestion with
this enzyme separates the nef gene from the promoter and
should prevent its transcription. Both pNEF-Neo and pNEF-
fs-Neo were as active as pMClNeopolyA at generating G418-
resistant colonies when digested with HindIll, demonstrating
that the effects observed are not due to the different environ-
ment of the neo cassette. Digestion at the KpnI site, 226 bp
downstream from the Nef start codon, also abolished the
inhibitory actions of both the control and frameshift expression
plasmids (Table 4). By contrast, digestion at the BstEII site,
located downstream of the Nef coding sequence but 5' to the
heterologous rat preproinsulin polyadenylation signal, did not
prevent the inhibitory effects of the Nef and Nef-fs plasmids.
The inhibitory effects of nef did not totally preclude colony
formation. A selection of G418-resistant clones that did grow
were expanded, RNA was extracted, and expression of nef
transcript was examined by Northern (RNA) analysis. None
of the clones that were expanded expressed detectable nef
mRNA (data not shown). When selected clones were exam-
Vol. 67, 1993
.,
f
i
"Ilkt' tI
.A- ...
.4-.E_f v ,i.
6962 MURPHY ET AL.
ined by Southern blotting, clones derived from transfection
with HindIll-cut plasmid contained both nef and neo DNA,
whereas clones that might have been expected to express nef
contained no nef DNA. These results suggest that the only way
that a viable Neor line can be generated by using Nef-neo
plasmids is if the nefexpression cassette is either interrupted by
digestion prior to transfection or eliminated from the DNA
inserted into the genome. In summary, we were unable to
generate stable Nef-expressing RAW264 cell lines, but the
data indicate that Nef interferes with pathways that regulate
cell growth.
DISCUSSION
This report is concerned with the complex interactions
between extracellular regulators and viral and cellular gene
products that regulate transcription of HIV-1 in macrophages.
The murine macrophage cell line RAW264 was chosen for
study because it responds to a wide range of physiological
modulators and can be conveniently transfected with high
efficiency (3). We have shown that the HIV LTR is constitu-
tively highly active in RAW264 cells in transient transfection
analysis and can be trans activated further by the tat gene
product. The ability of tat to trans activate in mouse macro-
phages clearly contradicts claims that rodent cells lack cellular
proteins that collaborate with tat (8, 28). In our studies, the
activity of tat did not distinguish murine from human macro-
phages (compare Tables 1 and 2 and Fig. 2D).
The results obtained with the antisense TAR mutants of
HIV-CAT were qualitatively similar to those seen in HeLa
cells transfected with the same plasmids (9). In both systems,
the SAA double mutant caused the greatest effect on both
basal activity and tat trans activation (Fig. 1B). Direct binding
analysis of RNA produced from this mutant suggested that it
could not be recognized by tat (9). However, the TAR deletion
mutant studied in the experiment presented in Table 2, which
should completely disrupt the stem-loop structure formed in
TAR RNA, had a much more selective effect than did the SAA
mutant on tat trans activation of the HIV-LTR in RAW264
cells, causing little change in basal activity. This finding sug-
gests that the effect of the SAA double mutant on basal
promoter activity operates independently of its effect on the
formation of RNA secondary structures. One possibility is that
in addition to its function as a tat response element, TAR
contains a conventional cis-acting enhancer element bound by
a nuclear DNA-binding protein(s). RAW264 cells do contain
nuclear DNA-binding proteins that interact specifically with
the TAR region in electrophoretic mobility shift assays (2a),
and the effects of the mutations and deletions studied herein
on the binding activity of these proteins are currently being
studied. Alternatively, the mutations, which would be con-
tained in the 3' untranslated region of the mRNA produced,
might affect RNA processing or translation.
The roles of the nef gene are controversial, and considerable
uncertainty exists regarding its function in the cycle of infection
by HIV-1. Expression of a functional nef comprising all regions
of the native protein appears essential to the disease state in
the closely related simian immunodeficiency virus (SIV). An
SIV clone with a deletion in the nef gene was infectious in
macaques but caused no disease and actually protected in-
fected individuals against challenge with pathogenic wild-type
SIV (6). Conversely, Nef protein is recognized as a major
inducer of cytotoxic T-cell activity in HIV (19). Kestler et al.
(17) suggested that SIV nef was required for maintaining high
virus loads during the course of persistent infection in vivo but
had no effect on replication of the virus in vitro. One question
that arises is whether the assays carried out in vitro have
involved appropriate cells. There is strong evidence that cells
of the monocyte/macrophage lineage are major reservoirs of
infectious HIV. Infection of these cells may lead either directly
or indirectly to many of the symptoms of AIDS, including
dysfunctions of the central nervous system and gastrointestinal
tract (22, 32). One possible explanation for the effects of nef
deletions on the course of SIV infection is that nef plays a
unique role in macrophages. We have presented data to
support that view.
First, we showed that cotransfection of a nef expression
plasmid with pHIV-CAT or pGL-LTR into mouse or human
macrophage cell lines led to induction of reporter gene expres-
sion. This was not seen in the widely studied COS-1 simian
fibroblast line. Our finding stands in complete contrast to other
reports on the action of nef (14, 31), but these studies did not
involve macrophage cell lines. The increase in LTR activity
attributable to nef was independent of the direct repeat
enhancer or TAR regions of the LTR and was multiplicative
with the effects of Tat and the physiological regulator LPS (Fig.
2; Tables 1 and 2). The apparent cell lineage restriction of nef
trans activation suggests either an interaction with macrophage
cellular factors or a unique interaction between Nef and a
macrophage signal transduction pathway. Since Nef is a non-
nuclear protein, an indirect pathway of action seems likely. The
failure of nef to trans activate the urokinase plasminogen
activator promoter, which is phorbol myristate acetate respon-
sive in RAW264 cells (3), at least argues against the possibility
that nef action involves protein kinase C activation. Clear
evidence that Nef does alter cell function is seen in its
cytostatic activity (Table 4). Unfortunately, the cytostatic ac-
tivity militates against the production of stably transfected cell
lines expressing high levels of nef mRNA or protein, and
further progress will require the use of a vector system with an
inducible promoter.
Both the trans-activating effects of nef and its cytotoxic and
cytostatic effects on RAW264 cells were unaffected by a
frameshift mutation at amino acid 35, suggesting that either
the mRNA or the N-terminal amino acids of nef have biolog-
ical activity. Given the tight preservation of the nef reading
frame in natural HIV variants (23), assignment of a distinct
biological activity to the entire protein seems compelling. In
SIV in vivo, there appears to be strong selective pressure in
favor of functional reversion of stop mutations in nef (17). One
possibility is that the intact protein serves as a decoy antigen,
released from dying T lymphocytes but not expressed in a
functional manner on the surface of infected macrophages. It
would be of some interest to ascertain whether Nef-specific
cytotoxic T cells can kill HIV-infected macrophages. Con-
versely, there is other evidence that the N terminus of Nef
contains critical amino acids involved in its biological activity.
Luria et al. (21), in a study showing that nef overexpression
blocked the function of the interleukin-2 promoter in T cells,
noted that substitutions at positions 15, 29, and 33, all up-
stream of the frameshift in the nef-fs gene used in our study,
abolished this nef activity. The variant carrying these mutations
was referred to as Nef-2. While having no inhibitory effect on
the interleukin-2 promoter, Nef-2 was able to compete in trans
with the inhibitory effect of the functional nef gene product
Nef-1. These observations would support the proposal that the
nef gene product has at least two functional domains, at least
one of them residing in the N terminus.
nefmRNA is the most abundant of the small multiply spliced
transcripts from HIV-1 infected cells, and differently spliced
species appear with characteristic frequency in T cells and
macrophages (26). A role for nef mRNA, rather than its
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translation product, in some of the actions of the expression
plasmids is apparently favored by the data in Table 4. Linear-
ization of the parent and frameshift nef expression plasmids
with KpnI at bp 226 abolished the cytostatic activity of the
plasmid. Conversely, linearization immediately upstream of
the polyadenylation signal with BstEII increased the cytostatic
activity. Although these two digests are important controls
assuring us that cytostasis is not due to poison sequences in the
nef DNA, they do not necessarily imply that protein or RNA
sequences downstream of the KpnI site are essential to Nef
function. We have no way of ascertaining whether the cells
transfected with KpnI-digested plasmid express a Nef protein
truncated at amino acid 73. Analysis of the nef sequences using
the SEQL program on the ANGIS (Australian National Ge-
nome Information Service) computer reveals a number of
stable single-hairpin-loop RNA structures. Several have free
energy values similar to that of the stable stem-loop structure
formed by TAR RNA, especially structures between bases
8530 to 8624 and 8731 to 8831. The removal of these structures
could alter the stability of the resultant nefmRNA, so that it is
rapidly degraded or differently processed, resulting in altered
production of Nef protein. If the nef mRNA is involved in the
responses that we have documented, the long stable stem-loop
structures referred to above could play a role, being perceived
by the cell as double-stranded RNA. Macrophages respond to
intracellular polyribonucleotides by producing alpha inter-
feron (15). This process is primarily an antiviral defense which
entails numerous physiological consequences, including cessa-
tion of cell proliferation. Alpha interferon is indeed induced in
HIV-infected unstimulated human monocyte/macrophage
cells following replication of the virus (30).
In summary, we have suggested a positive role for the nef
gene product in regulation of HIV transcription in macro-
phages and a negative effect of the same product on cell growth
and proliferation. The combined effect of these activities may
help to subvert the macrophage from growth and the produc-
tion of its own gene products to the production of viral gene
products, a strategy common to many viruses.
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